vs
丹纳赫（DHR）与史密斯菲尔德食品（SFD）财务数据对比。点击上方公司名可切换其他公司
丹纳赫的季度营收约是史密斯菲尔德食品的1.6倍（$6.0B vs $3.8B），丹纳赫净利率更高（17.3% vs 6.6%，领先10.7%），丹纳赫同比增速更快（3.7% vs 0.8%），过去两年史密斯菲尔德食品的营收复合增速更高（5.5% vs 1.8%）
丹纳赫是总部位于美国华盛顿特区的医疗健康企业，聚焦生物技术、生命科学与诊断领域的产品研发。公司下设三大业务板块：生物技术板块开发治疗相关产品，生命科学板块覆盖疾病溯源、新疗法研发、药物疫苗与基因编辑技术的测试生产，诊断板块研发检测仪器，为全球生命健康产业提供核心支持。
史密斯菲尔德食品是全球规模最大的生猪养殖与猪肉加工企业，1936年由卢特父子创立，总部位于美国弗吉尼亚州史密斯菲尔德，现隶属于香港企业。公司在美国自营超500个农场，还与2000余家独立农场合作养殖生猪，业务覆盖墨西哥、波兰、德国等多个海外市场。
DHR vs SFD — 直观对比
营收规模更大
DHR
是对方的1.6倍
$3.8B
营收增速更快
DHR
高出2.9%
0.8%
净利率更高
DHR
高出10.7%
6.6%
两年增速更快
SFD
近两年复合增速
1.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $6.0B | $3.8B |
| 净利润 | $1.0B | $249.0M |
| 毛利率 | 60.3% | 13.4% |
| 营业利润率 | 22.6% | 8.8% |
| 净利率 | 17.3% | 6.6% |
| 营收同比 | 3.7% | 0.8% |
| 净利润同比 | 7.9% | 9.7% |
| 每股收益（稀释后） | $1.45 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHRSFD
| Q1 26 | $6.0B | $3.8B | ||
| Q4 25 | $6.8B | $4.2B | ||
| Q3 25 | $6.1B | $3.7B | ||
| Q2 25 | $5.9B | $3.8B | ||
| Q1 25 | $5.7B | $3.8B | ||
| Q4 24 | $6.5B | $4.0B | ||
| Q3 24 | $5.8B | $3.3B | ||
| Q2 24 | $5.7B | $3.4B |
净利润DHRSFD
| Q1 26 | $1.0B | $249.0M | ||
| Q4 25 | $1.2B | $327.0M | ||
| Q3 25 | $908.0M | $248.0M | ||
| Q2 25 | $555.0M | $188.0M | ||
| Q1 25 | $954.0M | $224.0M | ||
| Q4 24 | $1.1B | $205.0M | ||
| Q3 24 | $818.0M | $291.0M | ||
| Q2 24 | $907.0M | $301.0M |
毛利率DHRSFD
| Q1 26 | 60.3% | 13.4% | ||
| Q4 25 | 58.0% | 14.2% | ||
| Q3 25 | 58.2% | 12.8% | ||
| Q2 25 | 59.3% | 13.2% | ||
| Q1 25 | 61.2% | 13.5% | ||
| Q4 24 | 59.5% | 13.5% | ||
| Q3 24 | 58.7% | 14.3% | ||
| Q2 24 | 59.7% | 15.4% |
营业利润率DHRSFD
| Q1 26 | 22.6% | 8.8% | ||
| Q4 25 | 22.0% | 9.5% | ||
| Q3 25 | 19.1% | 8.3% | ||
| Q2 25 | 12.8% | 6.9% | ||
| Q1 25 | 22.2% | 8.5% | ||
| Q4 24 | 21.8% | 8.5% | ||
| Q3 24 | 16.5% | 8.5% | ||
| Q2 24 | 20.3% | 9.8% |
净利率DHRSFD
| Q1 26 | 17.3% | 6.6% | ||
| Q4 25 | 17.5% | 7.7% | ||
| Q3 25 | 15.0% | 6.6% | ||
| Q2 25 | 9.3% | 5.0% | ||
| Q1 25 | 16.6% | 5.9% | ||
| Q4 24 | 16.6% | 5.2% | ||
| Q3 24 | 14.1% | 8.7% | ||
| Q2 24 | 15.8% | 8.8% |
每股收益（稀释后）DHRSFD
| Q1 26 | $1.45 | — | ||
| Q4 25 | $1.69 | $0.83 | ||
| Q3 25 | $1.27 | $0.63 | ||
| Q2 25 | $0.77 | $0.48 | ||
| Q1 25 | $1.32 | $0.57 | ||
| Q4 24 | $1.50 | $0.54 | ||
| Q3 24 | $1.12 | $0.77 | ||
| Q2 24 | $1.22 | $0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.4B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $6.9B |
| 总资产 | — | $12.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DHRSFD
| Q1 26 | — | $1.4B | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
总债务DHRSFD
| Q1 26 | — | — | ||
| Q4 25 | $18.4B | $2.0B | ||
| Q3 25 | $16.9B | $2.0B | ||
| Q2 25 | $17.4B | $2.0B | ||
| Q1 25 | $16.5B | $2.0B | ||
| Q4 24 | $16.0B | $2.0B | ||
| Q3 24 | $17.5B | — | ||
| Q2 24 | $17.0B | — |
股东权益DHRSFD
| Q1 26 | — | $6.9B | ||
| Q4 25 | $52.5B | $6.8B | ||
| Q3 25 | $51.1B | $6.5B | ||
| Q2 25 | $52.3B | $6.3B | ||
| Q1 25 | $50.8B | $6.2B | ||
| Q4 24 | $49.5B | $5.8B | ||
| Q3 24 | $51.3B | — | ||
| Q2 24 | $49.9B | — |
总资产DHRSFD
| Q1 26 | — | $12.0B | ||
| Q4 25 | $83.5B | $12.2B | ||
| Q3 25 | $79.9B | $11.5B | ||
| Q2 25 | $81.6B | $11.2B | ||
| Q1 25 | $79.1B | $11.1B | ||
| Q4 24 | $77.5B | $11.1B | ||
| Q3 24 | $80.6B | — | ||
| Q2 24 | $78.6B | — |
负债/权益比DHRSFD
| Q1 26 | — | — | ||
| Q4 25 | 0.35× | 0.29× | ||
| Q3 25 | 0.33× | 0.31× | ||
| Q2 25 | 0.33× | 0.32× | ||
| Q1 25 | 0.32× | 0.32× | ||
| Q4 24 | 0.32× | 0.34× | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | — |
| 自由现金流经营现金流 - 资本支出 | $1.1B | — |
| 自由现金流率自由现金流/营收 | 18.2% | — |
| 资本支出强度资本支出/营收 | 4.0% | 2.3% |
| 现金转化率经营现金流/净利润 | 1.28× | — |
| 过去12个月自由现金流最近4个季度 | $5.3B | — |
8季度趋势，按日历期对齐
经营现金流DHRSFD
| Q1 26 | $1.3B | — | ||
| Q4 25 | $2.1B | $938.0M | ||
| Q3 25 | $1.7B | $13.0M | ||
| Q2 25 | $1.3B | $274.0M | ||
| Q1 25 | $1.3B | $-166.0M | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.4B | — |
自由现金流DHRSFD
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.7B | $842.0M | ||
| Q3 25 | $1.4B | $-75.0M | ||
| Q2 25 | $1.1B | $196.0M | ||
| Q1 25 | $1.1B | $-245.0M | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.1B | — |
自由现金流率DHRSFD
| Q1 26 | 18.2% | — | ||
| Q4 25 | 25.5% | 19.9% | ||
| Q3 25 | 22.6% | -2.0% | ||
| Q2 25 | 18.4% | 5.2% | ||
| Q1 25 | 18.4% | -6.5% | ||
| Q4 24 | 23.0% | — | ||
| Q3 24 | 21.0% | — | ||
| Q2 24 | 19.7% | — |
资本支出强度DHRSFD
| Q1 26 | 4.0% | 2.3% | ||
| Q4 25 | 5.4% | 2.3% | ||
| Q3 25 | 4.8% | 2.3% | ||
| Q2 25 | 4.2% | 2.1% | ||
| Q1 25 | 4.3% | 2.1% | ||
| Q4 24 | 7.9% | 2.1% | ||
| Q3 24 | 5.1% | 2.8% | ||
| Q2 24 | 5.0% | 2.3% |
现金转化率DHRSFD
| Q1 26 | 1.28× | — | ||
| Q4 25 | 1.77× | 2.87× | ||
| Q3 25 | 1.83× | 0.05× | ||
| Q2 25 | 2.41× | 1.46× | ||
| Q1 25 | 1.36× | -0.74× | ||
| Q4 24 | 1.86× | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.56× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
